DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Isentress (Raltegravir) - News


News related to Isentress (Raltegravir) and/or conditions it is approved for

Higher-Dose, Once-Daily Raltegravir Regimen for HIV-1
Source: Medscape HIV/AIDS Headlines [2017.09.26]
A 1,200-mg, once-daily regimen of raltegravir, in combination with tenofovir disoproxil fumarate and emtricitabine, is effective in patients with previously untreated HIV-1 infection, according to results from the ONCEMRK trial.
Reuters Health Information

Adverse Events of Raltegravir and Dolutegravir
Source: Medscape HIV/AIDS Headlines [2017.09.25]
Do commonly reported toxic adverse events associated with these drugs factor into the decision to discontinue ART?

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017